EBITDA CAGR uses clean operating EBITDA derived from reported operating income plus depreciation and amortization.
Over longer horizons, EBITDA CAGR averages -2.71% over 3 years and 35.57% over 5 years; the trailing 12 months came in at -3.74%. EBITDA CAGR shows how the company's operating profitability has grown before depreciation and amortization. This reflects the growth of the core business's cash-operating earnings power, independent of capital-intensity and accounting depreciation choices.
Healthcare Services Group, Inc. (HCSG)
EBITDA growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reported quarterly EBITDA; no daily interpolation. Q2 FY2026 (2026-06-30): $25.75M.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A Quote observation: 2026-10-06T19:12:07.318Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| Year | Start EBITDA | End EBITDA | Change | % Change |
|---|---|---|---|---|
| 2025 | $67.86M | $65.32M | −$2.54M | -3.74% |
| 2024 | $69.00M | $67.86M | −$1.15M | -1.66% |
| 2023 | $59.10M | $69.00M | +$9.90M | +16.74% |
| 2022 | $78.80M | $59.10M | −$19.70M | -24.99% |
| 2021 | $14.27M | $78.80M | +$64.53M | +452.29% |
| 2020 | $91.82M | $14.27M | −$77.55M | -84.46% |
| 2019 | $109.51M | $91.82M | −$17.69M | -16.15% |
| 2018 | $135.78M | $109.51M | −$26.27M | -19.35% |
| 2017 | $125.25M | $135.78M | +$10.53M | +8.40% |
| 2016 | $96.71M | $125.25M | +$28.54M | +29.51% |
| 2015 | $37.35M | $96.71M | +$59.36M | +158.94% |
| 2014 | $68.99M | $37.35M | −$31.64M | -45.86% |
| 2013 | $72.46M | $68.99M | −$3.47M | -4.79% |
| 2012 | $61.19M | $72.46M | +$11.27M | +18.42% |
| 2011 | $55.26M | $61.19M | +$5.93M | +10.73% |
| 2010 | $47.94M | $55.26M | +$7.32M | +15.27% |
| 2009 | $44.78M | $47.94M | +$3.16M | +7.06% |
| 2008 | $47.08M | $44.78M | −$2.30M | -4.88% |
| 2007 | $38.12M | $47.08M | +$8.95M | +23.48% |
| 2006 | $29.47M | $38.12M | +$8.65M | +29.35% |
| 2005 | $24.20M | $29.47M | +$5.27M | +21.79% |
| 2004 | $17.98M | $24.20M | +$6.22M | +34.60% |
| 2003 | $15.53M | $17.98M | +$2.45M | +15.79% |
| 2002 | $12.53M | $15.53M | +$3.00M | +23.92% |
| 2001 | $10.36M | $12.53M | +$2.17M | +20.94% |
| 2000 | $10.00M | $10.36M | +$360.01K | +3.60% |
| 1999 | $15.20M | $10.00M | −$5.20M | -34.21% |
| 1998 | $11.40M | $15.20M | +$3.80M | +33.33% |
| 1997 | $12.50M | $11.40M | −$1.10M | -8.80% |
| Period | Period End | Value | QoQ Growth | YoY Growth |
|---|---|---|---|---|
| Q2 FY2026 | 2026-06-30 | $25.75M | -31.6% | N/A |
| Q1 FY2026 | 2026-03-31 | $37.64M | +28.1% | +48.1% |
| Q4 FY2025 | 2025-12-31 | $29.38M | -45.2% | +64.6% |
| Q3 FY2025 | 2025-09-30 | $53.61M | N/A | +135.9% |
| Q2 FY2025 | 2025-06-30 | -$36.55M | N/A | N/A |
| Q1 FY2025 | 2025-03-31 | $25.42M | +42.4% | +0.7% |
| Q4 FY2024 | 2024-12-31 | $17.85M | -21.4% | -49.1% |
| Q3 FY2024 | 2024-09-30 | $22.72M | +1015.0% | N/A |
| Q2 FY2024 | 2024-06-30 | $2.04M | -91.9% | -84.9% |
| Q1 FY2024 | 2024-03-31 | $25.24M | -28.0% | +46.1% |
| Q4 FY2023 | 2023-12-31 | $35.04M | N/A | +48.6% |
| Q3 FY2023 | 2023-09-30 | -$1.96M | N/A | N/A |
| Q2 FY2023 | 2023-06-30 | $13.49M | -21.9% | +0.4% |
| Q1 FY2023 | 2023-03-31 | $17.28M | -26.8% | -4.9% |
| Q4 FY2022 | 2022-12-31 | $23.59M | +432.9% | +343.6% |
| Q3 FY2022 | 2022-09-30 | $4.43M | -67.1% | -71.3% |
QoQ Growth compares the previous fiscal quarter; YoY Growth compares the same fiscal quarter in the prior fiscal year. Missing or ambiguous fiscal periods render N/A.
